Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00317616 · ClinicalTrials.gov registry record

The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study

A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by University of Miami.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT00317616 is a study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by University of Miami. The registered enrollment target is 500 participants, below the 893-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00317616, a study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

Pre-fALS is a prospective natural history and biomarker study of people not yet affected with ALS, but who are at genetic risk for developing ALS. The investigators aim to recruit unaffected (healthy) people from familial ALS (fALS) pedigrees in which a known genetic mutation associated with ALS has been identified; for this study, a fALS pedigree is one with two biologically related individuals who have or have had ALS and/or FTD. Individuals who may be at genetic risk for ALS and who belong to families with at least one affected family member who has tested positive for a known ALS genetic mutation may also be eligible to participate. Our goal is to study the pre-symptomatic phase, onset and progression of ALS and to learn more about genetic and environmental factors that put people at risk for developing ALS.

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2006-04
Est. Completion 2037-12

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT00317616

The ClinicalTrials.gov registry entry for NCT00317616 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 893-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (44% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT00317616 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00317616 about?

NCT00317616 is a clinical study titled "The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study". Pre-fALS is a prospective natural history and biomarker study of people not yet affected with ALS, but who are at genetic risk for developing ALS. The investigators aim to recruit unaffected (healthy) people from familial ALS (fALS) pedigrees in which a known genetic mutation associated with ALS has...

What is the current status of trial NCT00317616?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2006-04. Estimated completion is 2037-12.

What conditions does trial NCT00317616 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.

Who is sponsoring clinical trial NCT00317616?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00317616 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.